Dr Gill Lowe is a haematology specialist and is a clinical research fellow in the Birmingham Platelet Group. She helps to run the patient recruitment and make sure the study has ethical approval at all of our centres. She also tests patient’s platelets when samples arrive in the lab and compiles reports for the referring doctors.
Professor Steve Watson is a British Heart Foundation Professor in Cardiovascular Sciences and Cellular Pharmacology. He is head of the Birmingham Platelet Group and Chief Investigator on the GAPP project
Dr Neil Morgan is a lecturer in Cardiovascular Genetics. His current research is focussing on the molecular genetics of patients with platelet bleeding disorders and low platelet counts (thrombocytopaenia). The identification of novel gene defects would provide clues to genes and proteins involved in normal platelet physiology and ultimately lead to devising new treatment strategies to minimise the risk of bleeding in such patients
Gayle Halford is a research administrator in the Birmingham Platelet Group. She helps with the day to day running of GAPP including ethics applications, correspondence with the clinical research network, organising patient appointments and answering queries.
Rachael Taylor is a research associate and PhD student working on GAPP in Birmingham. She recently moved to join the group, and previously worked on a clinical research project in Manchester looking at patients with vascular disease. She will be involved in patient recruitment and testing within GAPP.
Dr Marie Lordkipanidzé is a pharmacist with a background in cardiovascular research. Her major research interest is to individualise therapy based on each patient’s specific needs, by bringing together powerful tools investigating the behaviour of platelets and the genetic makeup of each individual to determine the best antiplatelet drugs for each patient.
Andrew Mumford is the Reader in Haematology at the University of Bristol and director of the Bristol haemophilia comprehensive care centre. Dr Mumford's GAPP study laboratory contributes to deep phenotyping study participants and development of next generation sequencing strategies.
Stuart Mundell is a Senior British Heart Foundation Research Fellow and Reader in the School of Physiology and Pharmacology at the University of Bristol. His research laboratory examines the functional consequences of mutations in proteins identified through the GAPP project. The characterization of these mutations not only helps us understand how these platelet expressed proteins work but also reveals important insights into how individual protein function impacts upon platelet activity.
Mike Makris is a reader in haemostasis and thrombosis at the University of Sheffield and director of the Sheffield haemophilia and thrombosis centre
Martina Daly is a Senior Lecturer with the Haemostasis Research Group in the Department of Cardiovascular Science at the University of Sheffield. Through the GAPP project, they are contributing to the next generation sequencing of patients with platelet-based bleeding disorders and to the studies relating genotype with phenotype. They are also examining how mutations in platelet genes can contribute to the expression and diagnosis of type 1 von Willebrand disease, a disorder which phenotypically resembles some platelet bleeding disorders.